HIV incidence and related deaths in sub-Saharan Africa could significantly increase following the suspension of funding for ...

Global Fund notes that the US has contributed more than $26.31 billion to date and pledged up to $6 billion for the Seventh ...

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global AIDS response is in crisis after a major ...

GENEVA/JOHANNESBURG - UNAIDS today launched its 2025 Global AIDS Update, AIDS, Crisis and the Power to Transform, which shows ...

As Uganda grapples with a resurgence of new HIV infections, we must confront the uncomfortable truth: complacency is our ...

USAID has been present in Uganda for over sixty years. It has funded development in agriculture, education and research in ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Members of Parliament from the Youth Monitoring Committee, as well as youth health advocates, are calling on the central ...

In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing Lenacapavir (brand name Yeztugo)—a groundbreaking HIV treatment—at a cost ...